Viewing Study NCT05981703


Ignite Creation Date: 2025-12-24 @ 7:12 PM
Ignite Modification Date: 2025-12-29 @ 3:05 PM
Study NCT ID: NCT05981703
Status: RECRUITING
Last Update Posted: 2025-10-24
First Post: 2023-07-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
Sponsor: BeiGene
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module